The Pharma industry is passing through a turbulent phase, the industry has been witnessing a drastic dip in R&D productivity and revenue streams are under threat from near expired drug patents. In the near future there is an estimated loss of US $ 16 billion of revenue of marketed products.
For more details, download White Paper here:

Only registered and logged in users can download this file.